Teleconference Information - Tumor Treatment Field Therapy (TTFT) Contractor Advisory Committee Meeting - JD DME
Teleconference Information -Tumor Treatment Field Therapy (TTFT) Contractor Advisory Committee Meeting
Joint DME MAC Publication
The Centers for Medicare and Medicaid Services (CMS) assigned to the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) the task of developing local coverage determinations (LCDs) for processing and reviewing Medicare claims for Durable Medical Equipment, Prostheses, Orthoses, and Supplies (DMEPOS). The DME MACs have received a request from Novocure, the manufacturer of Optune®, to revise the Tumor Treatment Field Therapy (TTFT) LCD to include language indicating that TTFT is reasonable and necessary for newly diagnosed glioblastoma multiforme. The purpose of the Contractor Advisory Committee (CAC) is to discuss the scientific evidence underlying the requested LCD revision.
The CAC meeting will take place on March 6, 2019 in Baltimore, MD at the Centers for Medicare & Medicaid Services (7500 Security Blvd, Baltimore, MD 21244). The CAC meeting will begin at 9 a.m. and is scheduled to end at 4 p.m. (all times EST). Registration for in-person attendance is closed; however, interested stakeholders are invited to listen via teleconference or view the meeting via live stream on the CMS YouTube channel:
Teleconference
1-844-396-8222
WebEx Meeting Number: 907 357 926
CMS YouTube Channel URLs
Morning Session - https://www.youtube.com/watch?v=kRKdE3ny4dY
Afternoon Session - https://www.youtube.com/watch?v=S3BhpBS-TIA
